JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive: Some reviews published in the literature have already pointed out and discussed the relationship between constitutively activated JAK2/STAT signaling and deregulation of apoptosis-related genes in CML and human tumor cell lines [39,40].